XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restatement of Financial Statements (Tables)
 9 Months Ended
Sep. 30, 2021
Revision Of Prior Period Financial Statements [Abstract]  
Schedule of financial statements
   As Previously
Reported		   Adjustments   As Restated 
Audited Balance Sheet at December 23, 2020               
Warrant Liabilities  $
-
   $574,676   $574,676 
Total Liabilities   
-
    574,676    574,676 
Shares Subject to Possible Redemption   135,094,307    4,285,693    139,380,000 
Common Stock   479    (42)   437 
Additional paid-in capital   5,007,859    (4,860,327)   147,532 
Total Stockholders’ Equity   5,000,008    (4,860,369)   139,639 
                
Audited Balance Sheet at December 31, 2020               
Warrant Liabilities  $
-
   $580,860   $580,860 
Total Liabilities   303,738    580,860    884,598 
Shares Subject to Possible Redemption   134,983,359    4,399,888    139,383,247 
Common Stock   480    (43)   437 
Additional paid-in capital   5,118,821    (4,974,521)   144,300 
Accumulated Deficit   (119,298)   (6,184)   (125,482)
Total Stockholders’ Equity   5,000,003    (4,980,748)   19,255 
                
Audited Statement of Operations for the year ended December 31, 2020               
Change in Fair Value of Warrants  $
-
   $(6,184)  $(6,184)
Weighted average shares outstanding, basic and diluted   4,198,081    (4,198,081)   
-
 
Basic and diluted weighted average shares outstanding, common stock subject to redemption   
-
    339,344    339,344 
Basic and diluted weighted average shares outstanding, common stock not subject to redemption   
-
    3,429,593    3,429,593 
Basic and diluted net income (loss) per share   (0.03)   0.03    
-
 
Basic and diluted net income (loss) per share, common stock subject to redemption   
-
    52.43    52.43 
Basic and diluted net income (loss) per share, common stock not subject to redemption   
-
    (5.22)   (5.22)
                
Audited Statement of Changes in Stockholders’ Equity for the year ended December, 2020               
Issuance of Representative Shares on November 25, 2020 - Additional Paid-in-Capital  $
-
   $792,428   $792,428 
Issuance of Representative Shares on November 25, 2020 - Stockholders' Equity (Deficit)   15    792,428    792,443 
Initial Value of Private Warrants   
-
    (574,676)   (574,676)
Reclassification of offering costs related to Public Shares   
-
    3,655,046    3,655,046 
Other Offering Expenses   (532,623)   (792,428)   (1,325,051)
Net Loss   (155,543)   (6,184)   (121,727)
Maximum number of redeemable shares - Shares   (13,364,689)   (435,311)   (13,800,000)
Maximum number of redeemable shares - Par Value   (1,336)   (44)   (1,380)
Maximum number of redeemable shares - Paid-in-Capital   (134,982,023)   11,510,162    (123,471,861)
Maximum number of redeemable shares - Stockholders' Equity (Deficit)   (134,983,359)   11,510,118    (123,473,241)
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against additional paid-in-capital (“APIC”)   
-
    (19,561,805)   (19,561,805)
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC (interest earned on trust account)   
-
    (3,247)   (3,247)
                
Audited Statement of Cash Flows for the year ended December 31, 2020               
Net Loss  $(115,543)  $(6,184)  $(121,727)
Change in fair value of warrant liabilities   
-
    6,184    6,184 
Initial value of warrant liabilities   
-
    574,676    574,676 
Initial value of common stock subject to possible redemption   135,094,307    (11,621,066)   123,473,241 
Reclassification of offering costs related to Public Shares   
-
    (3,655,046)   (3,655,046)
Change in value of common stock subject to possible redemption   (110,948)   110,948    
-
 
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC   
-
    19,561,805    19,561,805 
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC (interest earned on trust account)   
-
    3,247    3,247 
                
Unaudited Balance Sheet as of March 31, 2021               
Common Stock subject to possible redemption  $134,522,628   $4,884,666   $139,407,294 
Common stocks, $0.0001 par value   485    (48)   437 
Additional paid-in capital   (5,345)   125,598    120,253 
Total stockholders’ equity (deficit)   5,000,011    (4,884,666)   115,345 
                
Unaudited Statement of Operations for the three months ended March 31, 2021               
Weighted average shares outstanding, basic and diluted   18,169,000    (18,169,000)   0 
Basic and diluted weighted average shares outstanding, common stock subject to redemption   
-
    13,800,000    13,800,000 
Basic and diluted weighted average shares outstanding, common stock not subject to redemption   
-
    4,369,000    4,369,000 
Basic and diluted net income (loss) per share  $0.01   $(0.01)  $
-
 
Basic and diluted net income (loss) per share, common stock subject to redemption   
-
    0.01    0.01 
Basic and diluted net income (loss) per share, common stock not subject to redemption   
-
    0.01    0.01 
                
Unaudited Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2021               
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC  $
-
   $(24,047)  $(24,047)
                
Unaudited Statement of Cash Flows for the three months ended March 31, 2021               
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC (interest earned on trust account)  $
-
   $24,047   $24,047